Leucas aspera - medicinal plant: a review. R Srinivasan, B Ravali, P Suvarchala, A Honey, A Tejaswini, P Neeraja | 60 | 2011 |
Review of brain and brain cancer treatment L Manoj, M Kalyani, K Jyothi, GG Bhavani, V Govardhani, R Srinivasan International Journal of Pharma and Bio Sciences 2, 468-477, 2011 | 12 | 2011 |
Synthesis and Antimicrobial Activity of some new α N-phthilimido amino acids analogues R Srinivasan, KR Kumar, PP Kumar International Journal of ChemTech Research 2 (2), 895-898, 2010 | 11 | 2010 |
Synthesis and antimicrobial activity of α N-Phthilimido and acetimido derivatives from amino acids and anhydrides. CUM Reddy, B Jayakar, R Srinivasan | 9 | 2010 |
Development And Validation Of New Spectroscopic Method For The Estimation Of Valgancyclovir Hcl In Bulk And Pharmaceutic Dosage Form NYSS Dr. R. Srinivasan, Sathish Kumar Konidala* World Journal Of Pharmaceutical Research 3 (3), 2277 – 7105, 2014 | 8* | 2014 |
Stability indicating RP-HPLC method for determination of azilsartan medoxomil in bulk and its dosage form R Srinivasan, JK Chandra, DR Kumar, ND Kumar Int J Pharm anal res. 2014; 3 (4): 445 52, 2014 | 8 | 2014 |
Study of Antidiabetic and Free Radical Scavenging Activity of the Methanolic and N-Hexane Extract of Asystasia gangetica Leaf in Alloxan Induced Diabetic Rats G Lakshmana, V Chitra, KD Rajesh, RP Dayakar, R Srinivasan, ... Research journal of Pharmacology and Pharmacodynamics 6 (2), 86, 2014 | 7 | 2014 |
Evaluation of anthelminthic activity of leaves of Quisqualis indica DSK Sarma, R Srinivasan, RD Kumar, D Nagajyothi, V Prabhavathi, ... World J Pharm Pharm Sci 4, 819-24, 2015 | 4 | 2015 |
A NEW RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF IMIPENEM AND CILASTATIN IN PHARMACEUTICAL DOSAGE FORM PC Dr.R.SRINIVASAN*,K.LURDHU MARY, D.RAJESH KUMAR Pharmanest-An International Journal of Advances in Pharmaceutical Sciences 5 …, 2014 | 3* | 2014 |
Analgesic, antipyretic, antimicrobial activity of whole Leucas aspera ethanolic extract R Srinivasan, G Lakshmana . Pharmanest 5 (2), 1980-1986, 2014 | 3* | 2014 |
Marines and microorganisms naturevolution of anti-cancer agents-a review R Srinivasan, G Lakshmana, DR KUMAR, B ANJANEYULU, DA KUMAR, ... IJAPS 5 (2), 357-365, 2014 | 2 | 2014 |
A validated LC Method for the Estimation of Rilpivirine in API and Pharmaceutical Dosage form DRSK Ravi, A Suneetha, N Srilakshmi Journal of Pharmacy Research 5 (8), 4434-4436, 2012 | 2 | 2012 |
Effect of Polymorphism on New Drug Formulation and Development: A Short Review SDE Shakthivel K.1*, Devi R.2, Srinivasan R.3 Global Journal of Noval Pharma and Paramedical Research 1 (1), 40-45, 2022 | 1* | 2022 |
Validation of Developed Analytical Methods for the Determination of Remoglifozin and Ertuglifozin in Pharmaceutical Dosage Forms - An Updated Review CASFA Dr. R. Srinivasan International Journal of Pharmaceutical Sciences Review and Research 72 (1 …, 2022 | 1 | 2022 |
Study of Diseases like Malaria, Chikungunya and Dengue caused by Mosquitoes in human kind. R Srinivasan, MD Raju, SD Prasad, ME Rao, G Harish, R Jogayya, ... International Journal of Pharmacy and Analytical Research 4 (2), 94-99, 2015 | 1 | 2015 |
Advancements and Challenges in Hot Melt Extrusion (HME) for Pharmaceutical Applications P Saranya, S Mahapatra, V Rakshana, R Srinivasan Journal of Pharma Insights and Research 2 (2), 110-114, 2024 | | 2024 |
Understanding Causes, Symptoms, and Treatment Options of Carnitine Deficiency K Dhanusha, E Elavarasi, R Srinivasan Journal of Pharma Insights and Research 2 (2), 104-109, 2024 | | 2024 |
Innovations in Nanoparticle-Mediated mRNA Delivery V Saraswathi, V Rakshana, S Abinaya, R Srinivasan Journal of Pharma Insights and Research 2 (2), 083-088, 2024 | | 2024 |
Synthesis and pharmacological evaluation of selective MAO-A inhibitors using structure and pharmacophore-based drug design MK Vijayalakshmi, AJ Suresh, S Vadivelan, L Kaviarasan, R Srinivasan, ... Journal of Molecular Structure 1301, 137302, 2024 | | 2024 |
Exploring Corporal Punishment Laws K Dhanusha, MK Vijayalakshmi, R Srinivasan Journal of Pharma Insights and Research 2 (1), 136-141, 2024 | | 2024 |